Minerva Imaging is happy to announce that we will be presenting some of our work at the AACR-NCI-EORTC International Conference 2019, October 26 – 30, 2019, Boston, Massachusetts.
Please join our co-founders Carsten H. Nielsen, CEO, and Andreas Kjaer, CSO, during the following presentations to learn more about some of our latest developments and capabilities:
- PET imaging of biomarkers in immuno-oncology for response prediction and treatment monitoring
Development of non-invasive PET imaging of PD-L1 and expression and imaging of CD4+ and CD8a+ tumor infiltrating lymphocytes for response prediction and treatment monitoring of immune stimulating therapies
- Preclinical models of breast cancer brain metastasis for drug efficacy studies
Development of tumor metastasis model using HER2-positive breast cancer cells. Injection of cells through intracranial stereotactic, intracarotid or intracardiac methods followed by MRI and bioluminescence imaging to follow growth and take of tumor
The program of the presentations is:
Sunday, October 27
- Poster Session
Preclinical models of breast cancer brain metastasis for drug efficacy studies, A011.
Poster session title: Animal Models. Time 12:30 PM to 4:00 PM. Hynes Convention Center, Hall D
Monday, October 28
- Spotlight on Proffered Papers Session
PET imaging of biomarkers in immuno-oncology for response prediction and treatment monitoring, B042.
Session title: Spotlight on Proffered Papers 2 (short talk). Time 11:50 AM to 12:20 PM. Hynes Convention Center, Hall D
The abstract will also be open for discussing during the following session. Poster session title: Imaging. Time 12:30 PM to 4:00 PM. Hynes Convention Center, Hall D
During our presentations we will be available for a talk about the many possibilities for collaboration. For a more in-depth discussion please feel free to reach out to schedule a meeting during the conference.